Holen Sie sich die Stockscreener-App
80.69
10.15%
-9.12
Handel nachbörslich:
81.10
0.41
+0.51%
Schlusskurs vom Vortag:
$89.81
Offen:
$85.87
24-Stunden-Volumen:
1.60M
Relative Volume:
1.64
Marktkapitalisierung:
$2.91B
Einnahmen:
$117.67M
Nettoeinkommen (Verlust:
$-1.88B
KGV:
-1.3329
EPS:
-60.5369
Netto-Cashflow:
$-621.36M
1W Leistung:
-6.57%
1M Leistung:
+23.11%
6M Leistung:
+125.55%
1J Leistung:
+477.18%
1-Tages-Spanne:
$80.60
$86.70
1-Wochen-Bereich:
$80.60
$95.25
52-Wochen-Spanne:
$13.52
$103.00
Grail Inc Stock (GRAL) Company Profile
Firmenname
Grail Inc
Sektor
Branche
Telefon
(833) 694-2553
Adresse
1525 O'BRIEN DRIVE, MENLO PARK
Vergleichen Sie GRAL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
80.69 | 3.24B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-10-17 | Eingeleitet | Guggenheim | Neutral |
Grail Inc Aktie (GRAL) Neueste Nachrichten
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference - WV News
Is GRAIL Inc. (NL0) stock undervalued historicallyJuly 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
GRAIL (GRAL): Assessing Valuation Following New SYMPLIFY Study Results and Rising Industry Recognition - simplywall.st
Why Is GRAL Stock Rising Today? - MSN
Identifying reversal signals in GRAIL LLCJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Manulife Becomes First Canadian Insurer to Offer the Galleri® Multi-Cancer Early Detection Test by GRAIL - The Globe and Mail
Will GRAIL Inc. (NL0) stock attract long term capital inflows2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
GRAIL (GRAL) Is Up 8.2% After Strong SYMPLIFY Data Underscores Galleri’s Early Cancer Detection Potential - Yahoo! Finance Singapore
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Purchases Shares of 4,525 GRAIL, Inc. $GRAL - MarketBeat
Why The Story Around GRAIL Is Shifting After Recent Analyst and Clinical Developments - Yahoo Finance
Pier Capital LLC Buys New Stake in GRAIL, Inc. $GRAL - MarketBeat
Did Positive SYMPLIFY Results Just Redefine GRAIL's (GRAL) Path in Early Cancer Detection? - simplywall.st
Focus Partners Advisor Solutions LLC Takes Position in GRAIL, Inc. $GRAL - MarketBeat
Brighton Jones LLC Makes New $283,000 Investment in GRAIL, Inc. $GRAL - MarketBeat
GRAIL (NASDAQ:GRAL) Trading 8.2% HigherHere's Why - MarketBeat
Class action complaint alleging GRAIL insider fraud resubmitted after dismissal - The Cancer Letter
Will GRAIL Inc. (NL0) stock boost dividends further2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
How a Texas congressman won support for a controversial cancer test - Houston Chronicle
What analysts say about GRAIL Inc NL0 stockStock Correlation Metrics & High Profit Stock Alerts - earlytimes.in
What technical patterns form on GRAIL Inc. (NL0) stock chartsJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com
GRAIL to Announce Third Quarter 2025 Financial Results - Lelezard
Published on: 2025-10-30 01:55:10 - newser.com
How Illumina/Grail Is Affecting EU Merger Control 1 Year On - Law360
Can GRAIL LLC stock rebound after recent weaknessJuly 2025 Highlights & Target Return Focused Picks - Fundação Cultural do Pará
GRAIL (GRAL) Price Target Increased by 51.85% to 62.73 - Nasdaq
Cathie Wood Just Dumped More Palantir Shares Despite 'Holy Grail' AI Deal — Here's What Ark Bought Instead - Benzinga
Groundbreaking blood test can detect more than 50 cancers, Bay Area biotech says - KTVU
Illumina, Grail seek to recoup litigation costs over EU merger fight - MLex
Can GRAIL Inc. (NL0) stock deliver double digit returnsJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Does GRAIL LLC stock trade at a discount to peersQuarterly Risk Review & Daily Oversold Stock Bounce Ideas - Fundação Cultural do Pará
Alex Karp Says New Lumen Deal Can Make AI Data '200x Faster,' 'Incrementally Cheaper:' 'The Holy Grail For Businesses' - Yahoo Finance
Samsung Electronics, Samsung C&T to invest US$110 mln in U.S. biotech firm Grail - MSN
Will GRAIL Inc. (NL0) stock keep raising dividendsPrice Action & Free Low Drawdown Momentum Trade Ideas - Fundação Cultural do Pará
GRAIL: Buy Τhe Test That Could Redefine Cancer Screening (NASDAQ:GRAL) - Seeking Alpha
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $226,000 Position in GRAIL, Inc. $GRAL - MarketBeat
Jim Cramer on GRAIL: “Don’t Call Yourself Early if You’re Buying This One” - MSN
Published on: 2025-10-26 21:05:02 - newser.com
GRAIL (GRAL): Evaluating Valuation After Key Study Results and Samsung Partnership Propel Global Growth Prospects - Sahm
Weiss Ratings Reaffirms "Sell (D-)" Rating for GRAIL (NASDAQ:GRAL) - MarketBeat
GRAIL (NASDAQ:GRAL) Trading 11.2% HigherTime to Buy? - MarketBeat
Grail’s Stock Surges After Samsung Collaboration in Asia - timothysykes.com
Carnegie Investment Counsel Takes Position in GRAIL, Inc. $GRAL - MarketBeat
Finanzdaten der Grail Inc-Aktie (GRAL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
6.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):